Index by Author

August 2009; 9 (4)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

B

  1. Berkowitz, Barry A.

    • Antiangiogenic Drugs: Insights into Drug Development from Endostatin, Avastin and Thalidomide Mol Interv August 2009 9:157-166; doi:10.1124/mi.9.4.2

C

  1. Christ, George J.

    • Regenerative Pharmacology for Diabetes Mellitus Mol Interv August 2009 9:171-174; doi:10.1124/mi.9.4.5

  2. Collinge, Dan

D

  1. Duncan, Michael B.

    • Parstatin, a Novel Protease-Activated Receptor 1–Derived Inhibitor of Angiogenesis Mol Interv August 2009 9:168-170; doi:10.1124/mi.9.4.4

F

  1. Feldman, Polina

  2. Furth, Mark E.

    • Regenerative Pharmacology for Diabetes Mellitus Mol Interv August 2009 9:171-174; doi:10.1124/mi.9.4.5

G

  1. Gaval-Cruz, Meriem

    • Mechanisms of Disulfiram-induced Cocaine Abstinence: Antabuse and Cocaine Relapse Mol Interv August 2009 9:175-187; doi:10.1124/mi.9.4.6

H

  1. Holaday, John W.

    • Antiangiogenic Drugs: Insights into Drug Development from Endostatin, Avastin and Thalidomide Mol Interv August 2009 9:157-166; doi:10.1124/mi.9.4.2

K

  1. Kalluri, Raghu

    • Parstatin, a Novel Protease-Activated Receptor 1–Derived Inhibitor of Angiogenesis Mol Interv August 2009 9:168-170; doi:10.1124/mi.9.4.4

M

  1. Miller, Richard J.

W

  1. Weinshenker, David

    • Mechanisms of Disulfiram-induced Cocaine Abstinence: Antabuse and Cocaine Relapse Mol Interv August 2009 9:175-187; doi:10.1124/mi.9.4.6

  2. White, Fletcher A.

Current Issue

  1. April 2011, 11 (2)
  1. Current Issue
  1. Alert me to new issues of MI
Society Logo HighWire Press Logo CLOCKSS logo